Source author record

Cai

Cai appears in the imported research catalog. Authorship, coauthor and topic links are available while profile ownership is still unclaimed.

ResearcherUnclaimed source record

Catalog footprint

What is connected

2works
2topics
4close collaborators

Actions

Connect this record

Log in to claim

Research graph

See the researcher in context

Open full explorer

Inspect adjacent papers, topics, institutions and collaborators without losing the researcher page.

Building this map preview

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

2 published item(s)

preprint2022arXiv

Multi-objective Optimization of Clustering-based Scheduling for Multi-workflow On Clouds Considering Fairness

Distributed computing, such as cloud computing, provides promising platforms to execute multiple workflows. Workflow scheduling plays an important role in multi-workflow execution with multi-objective requirements. Although there exist many multi-objective scheduling algorithms, they focus mainly on optimizing makespan and cost for a single workflow. There is a limited research on multi-objective optimization for multi-workflow scheduling. Considering multi-workflow scheduling, there is an additional key objective to maintain the fairness of workflows using the resources. To address such issues, this paper first defines a new multi-objective optimization model based on makespan, cost, and fairness, and then proposes a global clustering-based multi-workflow scheduling strategy for resource allocation. Experimental results show that the proposed approach performs better than the compared algorithms without significant compromise of the overall makespan and cost as well as individual fairness, which can guide the simulation workflow scheduling on clouds.

preprint2021arXiv

Independent Action Models and Prediction of Combination Treatment Effects for Response Rate, Duration of Response and Tumor Size Change in Oncology Drug Development

An unprecedented number of new cancer targets are in development, and most are being developed in combination therapies. Early oncology development is strategically challenged in choosing the best combinations to move forward to late stage development. The most common early endpoints to be assessed in such decision-making include objective response rate, duration of response and tumor size change. In this paper, using independent-drug-action and Bliss-drug-independence concepts as a foundation, we introduce simple models to predict combination therapy efficacy for duration of response and tumor size change. These models complement previous publications using the independent action models (Palmer 2017, Schmidt 2020) to predict progression-free survival and objective response rate and serve as new predictive models to understand drug combinations for early endpoints. The models can be applied to predict the combination treatment effect for early endpoints given monotherapy data, or to estimate the possible effect of one monotherapy in the combination if data are available from the combination therapy and the other monotherapy. Such quantitative work facilitates efficient oncology drug development.